InsiderClue
← All stocks

Apogee Therapeutics, Inc.

APGE Net selling
CIK 0001974640 #925 in the set updated 17 Sep 2026
Bought (120 mo)
$80.74M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$187.54M
$46.88M on a plan · $6.85M straight out of an exercise
Sold at will
$133.81M
2 of 131 sales
Net
−$106.80M
−$53.07M against sales at will

By person

8 insiders · 141 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fairmount Funds Management LLC entity
Director
$50.00M (3)
$133.53M (1)
−$83.53M
340,855
0.4524%
$45.73M
0.0%
HENDERSON MICHAEL THOMAS
Chief Executive Officer
—
$37.96M (50) scheduled
−$37.96M
0
0.0000%
$0.00
−100.0%
Shah Nimish P
Director
$29.75M (1)
—
+$29.75M
1,750,000
2.32%
$234.80M
0.0%
Dambkowski Carl
Chief Medical Officer
—
$13.67M (57) scheduled
−$13.67M
0
0.0000%
$0.00
−100.0%
Henderson Jane
Chief Financial Officer
—
$2.38M (23) scheduled
−$2.38M
0
0.0000%
$0.00
−100.0%
McKenna Mark C.
Director
$990.78K (2)
—
+$990.78K
0
0.0000%
$0.00
—
JONES WILLIAM A JR
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Fox Jennifer A.
Director
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
McKenna Mark C.
12 Dec 2024
Director
Buy
12,500
$49.85
$623.13K
McKenna Mark C.
12 Dec 2024
Director
Buy
7,500
$49.02
$367.65K
Fairmount Funds Management LLC
13 Jul 2023
Director
Buy indirect
892,529
$17.00
$15.17M
Fairmount Funds Management LLC
13 Jul 2023
Director
Buy indirect
1,992,734
$17.00
$33.88M
Fairmount Funds Management LLC
13 Jul 2023
Director
Buy indirect
55,913
$17.00
$950.52K
Shah Nimish P
13 Jul 2023
Director
Buy indirect
1,750,000
$17.00
$29.75M
Show all 141 transactions →

What was left out

Form 4 filings counted 113
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 95
Sales straight out of an exercise 34
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 4,853,766
History held since 17 Jul 2023